The JOURNAL OF CHILD NEUROLOGY is a distinguished publication in the critical fields of neurology and pediatrics, published by SAGE PUBLICATIONS INC. With its ISSN 0883-0738 and E-ISSN 1708-8283, this journal has been a pivotal resource since its inception in 1986, serving the needs of researchers, clinicians, and students dedicated to advancing the understanding and treatment of neurological disorders in children. As evidenced by its impressive Q2 rankings in both Neurology (clinical) and Pediatrics, Perinatology, and Child Health, the journal has established a reputable position within the academic community, ranking in the 75th percentile for pediatrics and the 53rd percentile for clinical neurology. This periodical not only contributes to the body of knowledge in child neurology but also promotes interdisciplinary collaboration, engaging a global audience through innovative research articles and case studies. Although the journal is not open access, it remains committed to disseminating high-quality research aimed at improving pediatric health outcomes, making it an essential read for professionals and researchers dedicated to this crucial area of medicine.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

PSYCHOLOGICAL REVIEW, published by the American Psychological Association, stands as a premier journal within the field of psychology, boasting an impressive track record since its inception in 1894. With an impressive impact factor and a distinguished position in Q1 quartiles for both History and Philosophy of Science and Miscellaneous Psychology, this journal is recognized as a leading source of innovative research and critical analysis. Consistently ranked in the top tier, it holds the 17th position out of 216 in general psychology according to Scopus, reflecting its significance and the high caliber of scholarly contributions it features. While the journal is not open access, it provides comprehensive insights geared towards researchers, professionals, and students keen to deepen their understanding of psychological theories and practices. With a commitment to fostering intellectual discourse, PSYCHOLOGICAL REVIEW is essential for anyone engaged in the evolving landscape of psychological research.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, published by WILEY, is a premier journal dedicated to advancing knowledge in the fields of developmental neuroscience, clinical neurology, and pediatrics. With an impressive impact factor, this journal is recognized for its contributions, achieving Q1 ranking in both Pediatrics, Perinatology and Child Health, and Neurology (Clinical) sectors, as well as Q2 in Developmental Neuroscience. Since its inception in 1958, the journal has been at the forefront of disseminating vital research that informs clinical practice and enhances child health outcomes. Researchers and practitioners benefit from its high-quality, peer-reviewed articles that address critical issues in child neurology, underpinned by a robust Scopus ranking and a formidable percentile standing in relevant categories. While currently not an open-access journal, it remains a key resource for those dedicated to the study of child development, particularly at its intersection with neurological health. With a commitment to excellence, DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY is an essential read for anyone engaged in the care and research of pediatric populations.

The INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE is a critical platform for disseminating cutting-edge research in the field of developmental biology and neuroscience. Published by WILEY, this esteemed journal has been contributing to the academic community since its inception in 1983, and continues to serve as a vital resource through to 2024. With an impact factor that reflects its influence in the field—ranking in Q3 for both Developmental Biology and Developmental Neuroscience—this journal presents an opportunity for researchers, professionals, and students alike to engage with pioneering studies and extend their understanding of complex developmental processes. Although not open access, the journal provides an essential repository of knowledge for those seeking to explore the nuances of neurological development and related disciplines. It actively supports academic discourse and research dissemination, thereby playing a significant role in advancing our collective understanding of developmental neuroscience.

Autism & Developmental Language Impairments is a pioneering peer-reviewed journal published by SAGE Publications Inc that focuses on advancing the understanding of autism spectrum disorders and language impairments across the developmental spectrum. Since its inception in 2016, this open access journal has provided a platform for researchers, practitioners, and educators to disseminate innovative research findings, clinical practices, and theoretical insights, reaching a global audience. The journal is notably indexed in prestigious databases and has established its credibility with a remarkable Rank of Q2 in both Clinical Psychology and Developmental and Educational Psychology as of 2023, solidifying its importance in these vital fields. Based in the United Kingdom, it addresses crucial issues in mental health, reflecting a commitment to fostering advancements that seek to enhance the lives of individuals affected by developmental language impairments. As it converges into its next phase from 2016 to 2024, Autism & Developmental Language Impairments continues to play an essential role in bridging gaps between academia and practice, making it an invaluable resource for researchers, clinicians, and students dedicated to this critical area of study.

CHILD PSYCHIATRY & HUMAN DEVELOPMENT, published by Springer, stands at the forefront of research in the fields of developmental and educational psychology, pediatrics, perinatology, and child psychiatry. With an ISSN of 0009-398X and an E-ISSN of 1573-3327, this esteemed journal has been a vital resource for academics since its inception in 1970. Currently ranked in the Q1 category across its multiple relevant disciplines, it illustrates a significant impact with its Scopus rankings, placing it within the top 13% for pediatrics and child health and the top 18% for developmental psychology. Its comprehensive scope ensures that leading-edge studies, reviews, and discourse are accessible, contributing greatly to the understanding of mental health and developmental processes in children. With no open access option, the journal maintains a commitment to high-quality, peer-reviewed content that is invaluable for researchers, healthcare professionals, and students alike, as they strive to advance their knowledge and practices in child psychology and human development.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, published by Springer/Plenum Publishers, is a premier academic journal dedicated to advancing knowledge in the field of autism and related developmental disorders. With an impressive impact factor reflecting its reputation for rigorous peer-reviewed research, this journal has firmly established itself within the Q1 category of Developmental and Educational Psychology, ranked #32 out of 360 journals in its category, placing it in the top 91st percentile. The journal covers a broad range of topics, including intervention strategies, developmental trajectories, and the neurobiology behind autism spectrum disorders, making it an essential resource for researchers, educators, and clinicians alike. Since its inception in 1979, the journal has maintained a commitment to disseminating significant findings that can contribute to better understanding and support for individuals with developmental disorders, promoting interdisciplinary dialogue and collaboration. While it is not offered as open access, the Journal of Autism and Developmental Disorders remains a vital platform for the dissemination of transformative research in this crucial area.

PSYCHOANALYTIC PSYCHOLOGY is a distinguished journal published by the Educational Publishing Foundation of the American Psychological Association, specifically tailored to the field of Clinical Psychology. With an ISSN of 0736-9735 and an E-ISSN of 1939-1331, this journal has been a pivotal platform for scholarly discourse since its inception in 1984 and will continue to serve the academic community through 2024. While the journal currently operates under traditional access options, it maintains a reputable presence in the field, reflected by its ranking in the Q3 category for Clinical Psychology as of 2023, and a Scopus percentile that places it in the 41st percentile among its peers. Aimed at researchers, professionals, and students alike, PSYCHOANALYTIC PSYCHOLOGY is committed to advancing psychoanalytic practice and education through the dissemination of rigorous research findings, theoretical discussions, and innovative clinical practices, solidifying its importance in the continuous evolution of psychological science.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.